Using a "one-drug-fits-all" approach is not going to be a successful paradigm in a complex disease like glioblastoma.
Andrew S. Chi, MD, PhD
Advertisement
Articles by Andrew S. Chi, MD, PhD
Advertisement
Latest Updated Articles
NYU Scientist Sees Hope Peeking Through Gloom of GlioblastomaOctober 4th 2016
Advertisement
Advertisement
Trending on OncLive
1
VGX-3100 Elicits Regression and Clearance in HPV-16/18–Associated Cervical HSILs
2
BCG Optimization Becomes a Priority as Durvalumab Gains a Role in High-Risk NMIBC
3
EVX-01 Plus Pembrolizumab Yields Neoantigen-Specific T-Cell Responses in Advanced Melanoma
4
Zanidatamab, CLDN18.2-Directed ADCs, Ivonescimab, and KRAS Inhibitor Data Headline Key GI Cancer Findings From ESMO 2026
5